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INTRODUCTION 
Diabetes Mellitus (DM) is a metabolic disorder with inappropriate 
hyperglycemia due to either inadequate insulin secretion or combination of insulin 
resistance and inadequate insulin secretion to compensatecausing disturbances of 
carbohydrate, protein and fat metabolism. It is a major endocrine cause of 
morbidity and mortality all over the world. The incidence and prevalence is 
increasing globally and it has severe impact on health system. 
Diabetes mellitus is the great clinical imitator with a wide range of signs 
and symptoms affecting all systems and every organ of the body. Skin is also 
frequently involved. Skin manifestations in diabetes are numerous and percentage 
varies from 30-71% indicating how common skin involved in diabetes.1, 2 
Various factors involved in skin manifestations are abnormal carbohydrate 
metabolism, other altered metabolic pathways, atherosclerosis, microangiopathy, 
neuron degeneration, and impaired host mechanisms. Thus skin is affected by both 
acute metabolic derangements and the chronic degenerative complications. 
Though there is no clear correlation between skin lesions and the severity of the 
diabetes, there may be correlation between skin manifestations and extracutaneous 
diabetic complications like vasculopathy and neuropathy. Skin disorders can be 
the presenting symptom or first sign of diabetes, hence by recognizing those 
cutaneous features, the underlying diabetes can be diagnosed promptly at an early 
stage thereby making the prognosis better. They are also known to be marker for 
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the course of the diabetes.This study was to analyze the prevalence and pattern of 
skin disorders among diabetic patients in our region.  
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REVIEW OF LITERATURE 
PREVALENCE AND INCIDENCE 
According to International Diabetes Federation estimates, around 415 
million people had DM in 2015 and this number is expected to rise to 642 million 
by 20403,4. India is home to 69.1 million people with DM and is estimated to have 
the second highest number of cases of DM in the world after China in 2015. The 
prevalence of DM in India ranges from 5–17%, with higher levels found in the 
southern part of the country and in urban areas3, 5. Indians are also believed to have 
a greater degree of insulin resistance and a stronger genetic predisposition to 
diabetes6. There are several reviews of various skin disorders related to diabetes 
mellitus7-13 
CLASSIFICATION14 
Diabetes can be classified into the following general categories: 
1. Type 1 DM: insulin dependent which is usually juvenile onset, associated 
with HLA DR3, DQB1*0201 and DR4 and diabetes‐associated 
autoantibodies, and is prone to ketoacidosis. 
2. Type 2 DM: generally non‐insulin dependent and usually adult onset and 
associated with obesity. 
3. Secondary diabetes: iatrogenic or associated with pancreatic, hormonal and 
genetic disease. 
4. Gestational diabetes: associated with pregnancy.  
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CRITERIA FOR THE DIAGNOSIS OF DIABETES14 
Fasting plasma glucose (FBS) ≥ 126 mg/dl (7.0mmol/L) 
(or) 
2h plasma glucose (PPBS) ≥ 200 mg/dl (11.1mmol/L) during an OGTT 
(or) 
HbA1C ≥ 6.5% 
(or) 
Classic diabetes symptoms + Random blood sugar (RBS) ≥ 200mg/dl 
(11.1mmol/L) 
IMPORTANCE OF CUTANEOUS MANIFESTATIONS IN DIABETES 
MELLITUS15 
1. Many cutaneous diseases precede the onset of diabetes mellitus.  
2. Certain complications gives clue to current and past metabolic status. 
3. Some are cutaneous markers for the diagnosis of diabetes mellitus16. 
4. Recognition of cutaneous markers may slow the disease progression and 
improve the overall prognosis by enabling early diagnosis and treatment16 
5. Serious life threatening skin presentations can occur.  
6. Minor skin infections potentiate major complications and serve as a key to 
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the prevention and treatment of complications.   
7. Some skin manifestations reflect duration of diabetes.  
THE CLASSIFICATION OF CUTANEOUS MANIFESTATIONS OF 
DIABETES MELLITUS17: 
1. INFECTIONS – 
(i) Fungal like candidiasis, dermatophytosis, pityriasis versicolor 
(tinea versicolor), mucor mycosis.  
(ii) Bacterial like furunculosis, carbuncle, ecthyma, erythrasma, 
paronychia, erysipelas. 
(iii) Viral infections like herpes zoster, verucca. 
2. VASCULAR DAMAGE – Leg ulcerations, wet gangrene of foot, 
erysipelas like erythema, diabetic dermopathy, Rubeosis diabeticorum, 
Calciphylaxis 
3. NEUROLOGICAL DAMAGE – Charcot arthropathy, diabetic foot ulcer, 
neuropathy- sensory, autonomic, motor. 
4. OBESITY AND HYPERLIPIDEMIA RELATED DISEASES – acanthosis 
nigricans, acrochordons, eruptive xanthomas. 
5. GRANULOMATOUS DISORDERS – Necrobiosis lipoidica, granuloma 
annulare 
6. STIFF SKIN AND JOINTS – cheiroarthropathy, finger pebbles and 
scleredema diabeticorum. 
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7. DISEASES ASSOCIATED WITH DIABETES MELLITUS – diabetic 
bullae, pruritus, Nephrogenic fibrosing dermopathy, yellow skin and nail, 
lichen planus, psoriasis, Perforating dermatoses like reactive perforating 
collagenosis, autoimmune diseases like addisons, hypothyroidism (pretibial 
myxedema), coeliac disease(dermatitis herpetiformis), vitiligo, alopecia 
areata, Genetic diseases like werner syndrome, lipoid proteinosis, 
autoimmune polyendocrinopathy syndrome, systemic diseases like 
acromegaly, Lipodystrophy, Cushing syndrome, Haemochromatosis etc.. 
8. TREATMENT RELATED SKIN MANIFESTATIONS – insulin 
lipodystrophy, allergic reactions to insulin and oral hypoglycemic drugs. 
PATHOGENESIS OF SKIN DISORDERS IN DIABETES MELLITUS18 
Pathophysiology of skin disorders in diabetes is poorly understood19. Skin 
disorders in diabetes is caused by either diabetes induced metabolic changes in 
skin or by associated complications like vasculopathy and neuropathy. Diabetic 
complications are caused by direct damage caused by hyperglycemia and also by 
hyperglycemia induced non-enzymatic glycosylation of structural and regulatory 
proteins, lipids and nucleic acids. This causes accumulation of advanced 
glycosylation products (AGE)20.  
Specific receptors are present in many cell surfaces for the AGE. This 
initiates the different intracellular signaling cascade that can cause the diabetic 
complications. This AGE causes inhibition of keratinocyte proliferation and 
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migration, protein biosynthesis, inducing endothelial cell apoptosis, decreasing 
nitric oxide synthesis and impairing phagocytosis and chemo-taxis from several 
cells18, 20.Also AGE act in several ways, causing reactive oxygen species (ROS) 
formation, impairing ROS clearance, as well as intra and extracellular proteins 
dysfunction thus inducing pro inflammatory cytokines through nuclear factor κβ 
(NF-κβ) pathway21.They alters collagen properties by decreasing flexibility and 
solubility and increasing its rigidity22. Also, AGEs plays a major role in the 
development of fibrosis in DM23, in skin aging21 and in diabetes-related 
immunosuppression24. This Diabetes-related immunosuppression affects skin 
wound healing by leukocyte impaired function and malfunction of growth 
factors25. 
Bertheim et al. showed that diabetic patients with severe joint mobility on 
the hands had an increased epidermal thickness, with abnormal hyaluronic acid 
distribution on skin layers26. 
Due to altered action of insulin on keratinocyte proliferation, differentiation 
and migration it causes impaired epidermal barrier function and delayed wound 
healing27-29.Also skin surface pH in intertriginous regions of diabetics is 
significantly elevated compared to non-diabetic patients30. In additional normal 
stratum corneum hydration, reduced sebaceous gland activity and altered skin 
elasticity is noted31.   
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CUTANEOUS INFECTIONS IN DIABETES MELLITUS:  
Infections can be the presenting sign and symptom of diabetes especially in 
type 2. Diabetics are said to be more prone for infection because of its influence 
on various factors32 as follows: 
(1) Immunological defect (local and systemic): 
 Chemo-taxis, phagocytosis, migration and intracellular killingof the 
polymorphonuclear leucocytes are greatly reduced in diabetics when 
compared to others. 
 Phagocytic ability of polymorphs are reduced when plasma glucose level 
> 250mg/dl. 
 Lymphocyte transformation in response to mitogen phytohaemagglutinin 
was diminished in diabetic patients. 
(2) Non-immunological factors: 
 Level of glucose control: Candida albicans infection has direct correlation 
to the concentration of glucose especially in the saliva.  
 Peripheral vascular disease common in diabetics increases the risk of 
infections.  
 Also macro-vascular and micro-vascular dysfunction results in 
compromised local circulation leading to delayed response to infection 
and impaired wound healing. 
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 Sensory neuropathy makes the patient unaware of trauma, causing 
inadequate attention and more prone for secondary infection.   
 Xerosis of the skin also predisposes to skin infection.  
1) FUNGAL INFECTIONS  
A) Candidal infections 
Candida of the mucosa, nail folds, flexures, genitalia are more common in 
poorly controlled diabetes. It can cause angular cheilitis, oral thrush, vulvo-
vaginitis, balanoposthitis, intertrigo, paronychia and onychomycosis. They may be 
the only presenting feature of Diabetes mellitus. Many physicians believe that 
diabetes increases the risk of candida vulvovaginitis
33
. Hyperglycemia promotes 
yeast adhesion and decreases its phagocytosis
34
. The ratio of epidermal glucose to 
blood glucose is higher in diabetics, an environment that is more favourable for 
the yeast and fungal growth35. The saliva of diabetic patient is shown to produce 
candida growth in vivo in a study36 and they are more prone for oral candidiasis.  
Oral Mucosal candidiasis19 
Various forms of oral mucosal candidiasis include thrush (curdy white 
plaques over oral mucosa),atrophic candidiasis that manifests as bright red atrophy 
of the hard palate or tongue and angular cheilitis(perlèche), which presents as 
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erosions along labial commissures. Antifungal creams usually are required to 
eradicate the infection. Oral fluconazole tablets can be also given. 
Candidal paronychia 
9.8% of the diabetic women have paronychia compared to 3.4% in non-
diabetics females37. Patient who immerse their hand frequently in water are more 
prone to this condition38. Typically begins with erythema, swelling, and pain at the 
lateral nail fold then leads to separation of lateral nail fold from the nail margin 
and later cuticle is lost15. Purulent drainage may be seen in candidal paronychia. 
This is  typically characterized by intermittent exacerbations that may result in a 
nail plate dystrophy. Treatment includes keeping the hands as dry as possible, 
wearing of cotton gloves under rubber or vinyl gloves during dish washing. 
Topical antifungal solutions usually are adequate for treatment; however 
refractory cases may require oral therapy with an imidazole like fluconazole. 
Candidal intertrigo 
Candidal intertrigo particularly erosio interdigitalis blastomycetica is 
common in diabetics in between the third and fourth finger. 
Vulvovaginal candidiasis 
This is characterized by pruritus, vulval erythema, fissuring and rarely 
pustules. Severity of pruritus is directly proportional to the degree of glycosuria 
and hyperglycemia 39.Use of contraceptive pills, broad spectrum antibiotics and 
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steroids increases the risk many fold. Non-candida albicans are recognized more 
now in diabetics which are resistant to conventional antifungals.39 Oral nystatin 
reduces the reservoir of candida in gastrointestinal tract. 
Candidal balanitis19 
It can presents as diffuse or focal erythema of the glans penis, erosions, 
pustules with pain and pruritus. Middle aged to elderly men with balanitis and 
phimosis should be evaluated for diabetes40. Topical or oral imidazole are the 
treatment of choice. Circumcision can be considered in refactory and recurrent 
cases. 
B) Dermatophyte infections 
Tinea pedis (athlete’s foot) is more prevalent in diabetes than in the general 
population41. So the web spaces becomes scaly, itchy, macerated even vesicles and 
pustules can occur. Breaks in the normal skin barrier due to tinea may lead to 
erysipelas and cellulitis, and, ultimately, even to sepsis. Thus Tinea pedis should 
be promptly and aggressively treated in patients with diabetes mellitus 41. Oral 
azoles like fluconazole, Itraconazole or Allylamine like Terbinafine is given after 
monitoring blood counts, liver function tests and other drug interactions. 
Preventive foot care, including drying, wearing of cotton socks and sandals may 
help prevent infection. 
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Tinea corporis and Tinea cruris are common clinical types. Trichophyton 
rubrum was the commonest isolate followed by Trichophyton mentagrophytes42 
C) Mucor mycosis 
Mucormycosis (also known as Zygomycosis or Phycomycosis) is usually 
caused by the fungal species Mucor or Rhizopus which are found in decaying 
vegetations and food with high sugar content43. As the macrophages from patients 
with diabetes have decreased ability to attach to the hyphae of the fungus this 
impairs immune responses directed against this microorganism
44
. Rhinocerebral 
mucor mycosis is the most common and fulminating type of Zygomycosis which 
is invariably associated Diabetes mellitus. It presents as brownish, blood stained 
nasal discharge, black eschar covered ulcer on the palate, fixed and dilated pupil, 
proptosis, ptosis and complete ophthalmoplegia45. As the fungus can produce 
angiocentric infection it can cause thrombosis of the cavernous sinus and 
meningo-encephalitis. It is invariably fatal if not treated early by surgical 
debridement, correction of electrolyte imbalance and intravenous amphotericin-B. 
These phycomycetes may complicate the long standing leg ulcers in diabetics. 
D) Pityriasis versicolor  
Extensive Pityriasisversicolor are commonly seen in diabetes mellitus 
people 46 
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2) BACTERIAL INFECTIONS 
A) Primary bacterial infections 
Primary bacterial infections due to group A Streptococcus hemolyticus and 
Staphylococcus aureus are common in diabetic patients. Staphylococci colonize 
more in the lower extremity of patients with vasculopathy and neuropathy causing 
increased incidence of post operative infections than in non-diabetics47. Careful 
foot care and early treatment of dermatophytosis are essential in minimizing 
potential bacterial portals of entry. Furunculosis, carbuncle, cellulitis, erysipelas 
are much more common15. Diabetic patients are more likely to have methicillin-
resistant Staphylococcus aureus (MRSA) and MRSA- induced bullous erysipelas43 
B) Corynebacterial infections 
Erythrasma is a bacterial infection of the skin caused by Corynebacterium 
minutissimum characterised by well defined reddish brown scaly patches with 
irregular border. It involves intertriginous areas of the groin, axilla and toe webs. 
61% of diabetics are carriers of diptheroids and are associated with obesity.48 
Pitted keratolysis caused by Corynebacterium and other bacterias such as 
Dermatophilus congolensis, Kytococcus sedentarius are found to be common in 
diabetic people. 
Trichomycosis axillaris caused by Corynebacterium tenuis more common 
in diabetics in hot and humid environment. 
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C) Necrotizing fasciitis 
It is a life threatening poly-microbial infection caused by Group A 
streptococci,Enterococci, Staphylococcus aureus, E.coli and various anaerobes19. 
The perineum, trunk,extremities especially legs and abdomen are the most 
commonly involved sites. Patients are severely toxic and presents with erythema, 
swelling, induration, necrosis and bullae formation.49 
D) Malignant otitis externa 
A severe necrotizing bacterial infection usually due to Pseudomonas 
aeruginosa mainly affecting middle aged diabetics50. It causes severe ear pain, pus 
discharge and cranial nerve palsies and later spreads to adjacent soft tissue, 
cartilage, and bone. Extended therapy with anti-pseudomonal agents and surgical 
debridement are required.51 
3) VIRAL INFECTIONS 
There is increased risk of herpes zoster secondary to Varicella reactivation 
as cell mediated immunity decreases in diabetes people. There is also reports of 
disseminated cutaneous herpes zoster in patients with uncontrolled diabetes.   
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MANIFESTATIONS DUE TO VASCULAR DAMAGE 
PATHOPYSIOLOGY 
Hyperglycemia causing accumulation of advanced glycation end 
products18. AGE act in several ways, causing reactive oxygen species (ROS) 
formation, impairing ROS clearance, as well as intra and extracellular proteins 
dysfunction thus inducing pro inflammatory cytokine through nuclear factor κβ 
(NF-κβ) pathway.52  
1) MICRO AND MACROANGIOPATHY 
Microangiopathy17 is responsible for diabetic, retinopathy, nephropathy, 
neuropathy and dermopathy whereas large vessel disease or macroangiopathy 
manifests as atherosclerosis causing peripheral vascular disease, cerebro-vascular 
disease and ischemic heart disease. Cutaneous signs of microangiopathy are 
erysipelas like erythema, wet gangrene of the foot, diabetic rubeosis, diabetic 
dermopathy, periungual telangiectasia and nail changes8 
2) LEG ULCERATION 53 
It is a complication whose cause is multifactorial. Neuropathy (motor, 
sensory and autonomic) and microangiopathy are the factors, among which the 
neuropathy being the major factor. Lack of sensation makes the trauma to go 
unnoticed this may result in ulceration that is complicated by the defective 
microcirculation. Prolonged pressure on the subcutaneous tissue causes ischemic 
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fat necrosis due to vascular compromise and too much force exerted for a work out 
of proportion leads to ‘Mal perforans’. Risk factors for foot ulceration are 
duration, poor control of HbA1c level and peripheral neuropathy.54 A painless and 
slowly penetrating ulcer of the sole and of other pressure sites which is circular 
and punched out in shape, occurs in the middle of a callosity. The 
multidisciplinary approach including endocrinologist, neurologist, orthopedic 
surgeon, vascular surgeon, plastics and reconstructive surgeon is needed. 
Prevention is far more better than cure, hence care of the foot must become a 
routine in patients with diabetes.  
3) WET GANGRENE OF THE FOOT8 
Sudden loss of perfusion in a already compromised microcirculation results 
in wet gangrene of the foot. It is the late manifestation of diabetic 
microangiopathy. 
4) ERYSIPELAS-LIKE ERYTHEMA15 
Well-defined erythema occur on the legs or feet of elderly patients with an 
average duration of diabetes mellitus of 5 years. It heralds the onset of Charcot 
arthropathy. There is no fever, elevated ESR or leucocytosis and it seems to be an 
important sign of localized functional microangiopathy.   
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5) DIABETIC DERMOPATHY55 
Also called as shin spots or pigmented pretibial patches. Most common 
dermatosis associated with diabetes mellitus. Described by Melin56 as atrophic 
circumscribed brown patches in the front and sides of the lower portion of both the 
legs. Early lesions are small, flat-topped, dull, red painless papules later those 
lesions progress to atrophic hyper-pigmented irregular patches approximately 5 to 
12 mm in diameter.57 The lesions are most commonly located on the anterior shins, 
as well as on the forearms, anterior thighs, and feet more over bony 
prominences.35 Histologically the dermal arterioles and capillaries show thickening 
and PAS positive fibrillar material deposition in the vessel walls. Hemosiderin 
deposits due to extravasation of red blood cells are also seen. Diabetic dermopathy 
has been found to be associated with diabetic retinopathy, neuropathy, and 
nephropathy.58 
6) DIABETIC RUBEOSIS17 
A peculiar rosy reddening of the face and sometimes of the hands and feet 
may be seen. It has been attributed to diabetic microangiopathy or decreased 
vascular tone in long standing diabetes. Erythema occurs due to the decreased 
ability of the thickened dermal vessels to vasoconstrict59. Sun protection and 
avoidance of topical irritants and dietary vasodilators such as alcohol, coffee or tea 
may be helpful19. 
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7) CALCIPHYLAXIS60 
Calciphylaxis, also known as calcific uremic arteriolopathy, is a small-
vessel vasculopathy causing mural calcification with intimal proliferation, fibrosis, 
and thrombosis. It manifests as poor-healing, necrotizing skin ulcers with a livedo 
like reticular pattern. Risk factors are renal failure, female gender, white, obesity 
and diabetes(especially type 2 diabetes).61 Penile necrosis has been described in 
patients with a long history of diabetes on dialysis.62 
NEUROLOGICAL DAMAGE 
Elderly patients in whom the onset of diabetes is insidious are especially at 
risk of developing diabetic neuropathy due to damage to endoneural 
microvessels.17 Commonly, there is a distal symmetrical polyneuropathy with 
mixed motor and sensory nerve involvement.  
1) AUTONOMIC NEUROPATHY63 
Autonomic nervous system may be the first nervous tissue affected in 
diabetics and mostly affect the feet. The important physical finding is the 
decreased or absent sweating of the lower extremities with increased sweating 
elsewhere in the body. 
Thus it may lead to xerosis, cracking, fissuring , burns, ulcerations and 
callus.15 Patients with diabetic sensory neuropathy have accompanying autonomic 
involvement.  
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2) MOTOR NEUROPATHY  
Motor neuropathy of the foot is characterized by hammer toes, pescavus, 
subluxation of digits, distally displaced plantar fat pads and depressed metatarsal 
heads. 
3) SENSORY NEUROPATHY  
Patient complaints of tingling, numbness, burning sensation and aching 
symptoms more during night17 mainly in lower limbs. Restless leg and burning 
feet are common complaints. 
4) DIABETIC CHARCOT ARTHROPATHY 
Diabetic charcot arthropathy64 typically presents as a warm, swollen and 
erythematous foot and ankle mimicing cellulitis. It is due to a combination of 
motor, sensory and autonomic neuropathy. The foot becomes deformed with 
distally displaced plantar fat pads, depressed metatarsal heads, hammer toes and 
pescavus. It is due to circulatory abnormalities, trauma and abnormal pressure 
points leading to dislocation and the fusion of joints, fracture and bone resorption. 
Proper foot care is essential to prevent formation of perforating ulcers (‘mal 
perforans’).    
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OBESITY AND HYPERLIPIDEMIA RELATED SKIN DISEASES 
1) ACANTHOSIS NIGRICANS 
Smooth, velvety, hyperkeratotic, hyperpigmented skin17 predominantly 
affecting the flexures is most commonly seen in obese type 2 diabetic patients. It 
is the skin marker of insulin resistance states. Skin tags are commonly associated 
with them. Mutation in the insulin receptor, anti bodies to insulin receptor as well 
as post receptor mutation causes insulin resistance which leads to hyperglycaemia. 
The final common pathway is probably via stimulation of tyrosine kinase growth 
factor receptors in the epidermis 65 leading to excessive epidermal growth. 
Histologically, there is hyperkeratosis and papillomatosis as well as mild 
acanthosis of the epidermis.  
2) ACROCHORDONS17 
Skin tags are small, soft, pedunculated lesions occurring on the eyelids, 
neck and axillae, which are often associated with obesity. They are said to be the 
marker for diabetes, independent of obesity and acanthosis nigricans. 
3) XANTHOMAS 
A) Eruptive Xanthomas17 
Eruptive xanthomas may develop dramatically in diabetics with 
hyperlipidaemia resulting in a significant risk of pancreatitis. Decreased 
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lipoprotein lipase activity in IDDM results in elevated serum triglycerides level. 
Cutaneous xanthomas occurs when the serum triglyceride level rises to 1000 
mg/dl.66 It presents as multiple, small, reddish yellow papules over the extensor 
surfaces and buttocks. It is more common in males. The lesions slowly resolve 
when the diabetes and hyperlipidaemia are properly managed. 
Histopathology67shows admixture of non-foamy cells, among them 
macrophages, lymphocytes, neutrophils, whereas the number of well developed 
foamy cells are small. Extracellular lipids are found. Well-developed eruptive 
xanthomas are rich in foamy cells. 
B) Xanthelasma Palpebrarum  
It is characterized by plane xanthomas occurring more commonly in the 
eyelids. It is common in females. It is associated either with increase in serum 
cholesterol levels or no lipid abnormality. It does not regress even when therapy 
for diabetes is started.  
GRANULOMATOUS DISORDERS 
1) NECROBIOSIS LIPOIDICA  
First described by Oppenheim in 1929. One of the known cutaneous 
markers of diabetes mellitus. It occurs in 0.3-0.7% of diabetics.68 One study found 
that only 22% of NLD patients developed diabetes or impaired glucose tolerance 
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over a 15‐year follow‐up.69  Women are three times more commonly affected than 
men with an average age of onset of 30 years in patients with diabetes.  
The etiology of NLD remains unknown. Diabetic microangiopathy has 
been suggested etiology. The abnormal collagen is due to accelerated ageing of 
collagen in diabetes, abnormal collagen cross-linking, or overhydrated collagen 
produced in response to osmotic effects generated by the end products from the 
aldose reductase pathway.70 
The lesions are usually bilateral, asymptomatic occurring in the pretibial 
skin as irregular ovoid plaques, with violaceous indurated periphery and a yellow 
central atrophic area. Superficial telangiectasia may be noted. Ulceration occurs in 
35% of the cases.71Although most commonly found on the lower legs(85% of 
cases involve only the legs), other locations include the hands, fingers, forearms, 
face, and scalp.72 Patients may complain of pruritus, dysesthesia, or pain at the site 
of lesions. More frequently the lesions of NLD are asymptomatic, and it is the 
cosmetic concern to the patient. 
Histopathology of the skin lesion reveals necrobiotic reaction with large 
areas of necrobiotic collagen seen in the lower two third of the dermis and the 
infiltrate consisting of histiocytes, fibroblasts, lymphocytes surrounds the 
necrobiotic areas and adjacent fat. Giant cells may be seen and the extracellular 
lipid deposits are typical and scattered between the degenerating fibres. Blood 
vessels shows endothelial thickening and luminal occlusion.  
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Potent topical corticosteroids73 applied to the inflammatory rim of lesions 
are thought to help control disease progression. Other agents used with variable 
results includes fibrinolytic agents such as stanozolol, pentoxifylline, aspirin, 
dipyridamole, ticlopidine, nicotinamide, and clofazimine. Recent reports described 
the resolution of extensive ulcerative NLD with oral cyclosporine and 
mycophenolate mofetil.73 
2) GRANULOMA ANNULARE 
21% of generalized GA and 10% localized GA are associated with74  
diabetes. Majority of the diabetics are insulin dependent diabetes with increased 
prevalence of HLA B8. Immunoglobin G (Ig G) and C3 have been found in blood 
vessels of involved skin, suggesting an immunological role. 
It is clinically characterized by an annular or arciform configuration of 
flesh-colored or pale red papules and plaques located on the dorsa of the hands and 
feet. Generalised GA is characterized by a symmetrical eruption of hundreds of 
tiny papules, occurring all over the body surface. Mauriac’s75 syndrome is 
characterized by juvenile onset diabetes, stunted growth, hepatomegaly and 
granuloma annulare.  
Treatment is often unsatisfactory, but fortunately the disease is usually 
asymptomatic and self limiting. Localized disease is treated mainly by topical or 
intralesional steroid. Treatment of disseminated GA is difficult. Therapy includes 
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the use of systemic steroids, potassium iodide, antimalarials, nicotinic acid and 
dapsone.76 
STIFF SKIN AND JOINTS13 
Skin thickening and stiff joints are due to irreversible cross-linking of 
collagen and other proteins in the skin and accumulation of AGEs such as 
carboxymethyllysine and pentosidane receptors for AGE products stimulates 
several inflammatory and fibrogenic growth factors and cytokines via protein 
kinase C. There is no definitive treatment. Improved diabetic control is likely to be 
helpful. Aspirin reduces glycol-oxidative damage but the effect is slow. 
Physiotherapy may also help to maintain mobility. Other treatments include 
phototherapy, photophoresis, radiotherapy, prostacyclin, high dose penicillin, 
cyclosporine and factor XIII.  
1) FINGER PEBBLES77 
They are seen both in Type I and Type II diabetes mellitus. In diabetic 
patients with thick skin, the dorsal surfaces of the fingers develops tiny skin-
colored grouped papules77 and thickening giving a characteristic pebbled 
appearance over or near the knuckles called as ‘Huntley’s papules’ or 
‘Garrod’sknuckle  pads’.   
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2) DIABETIC THICK SKIN (CHEIRO ARTHROPATHY)17 
This is characterized by waxy tight skin on the backs of the hands and 
limited joint mobility (‘prayer sign’). It is an index of underlying microvascular 
changes neuropathy, retinopathy. It is demonstrated by inability to approximate 
the two palms with hands pressed together78 and fingers separated in extension 
called the “PRAYER SIGN”. It is due to the accelerated and irreversible non-
enzymatic glycosylation of the dermal collagen. 
3) SCLEREDEMA DIABETICORUM17 
The condition is mainly seen in overweight adults with type 2 diabetes. It is 
characterized by ill-defined induration of the skin, most commonly on the neck 
and upper back. Spread to the face, shoulder and anterior torso may occur.79 The 
skin retains a non pitting, woody, peau’d orange quality.80The pathogenesis is 
postulated to be unregulated production of extracellular matrix molecules by 
fibroblast leading to thickened collagen bundle and increased deposition of 
glycosaminoglycans. It is essentially permanent, painless and usually causes little 
morbidity.   
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DERMATOSES FREQUENTLY ASSOCIATED WITH DIABETES 
1) PRURITUS   
There is increased prevalence of truncal pruritus often in association with 
autonomic neuropathy.81In all cases systemic diseases should be ruled out. 
Anogenital pruritus may be due to candidiasis or haemolytic streptococci.8 
Persistent localized pruritus of the scalp is a sign of diabetic neuropathy82 and is 
extremely refractory to treatment.  
2) DIABETIC BULLAE  
Bullous diabeticorum or idiopathic bullae of diabetes are distinct markers 
of diabetes. It characterized by abrupt onset of painless and pruritic bullae on the 
leg and feet. Heals over several weeks without scarring. Histopathological 
examination of the bullae shows an inconsistent level of separation varying from 
intra epidermal  to sub-epidermal.83 Increased skin fragility may play a role in 
diabetic bullae. Perhaps the formation of advanced glycosylation end products 
lead to increased fragility.84 Treatment is symptomatic. 
3) PERFORATING DERMATOSES  
Kyrles disease, perforating folliculitis and acquired perforating dermatoses 
are noted in patients with diabetic nephropathy on hemodialysis.85 It is a chronic, 
usually asymptomatic disease consisting of bilateral scattered papules with horny 
 27 
cone shaped plugs, limited to the extensor surface of the arms, sacral region, legs, 
and buttocks. It is attributed to glycosylation of collagen and minor injury such as 
pressure or scratching.8 
4) YELLOW SKIN AND NAIL 
Yellow skin and nails have been reported to be more frequently seen in 
patients with diabetes due to carotene8 and non-enzymatic glycosylation of dermal 
collagen that eventually become yellow.  
5) GENETIC AND OTHER SYSTEMIC DISEASES  
Diabetes is a feature of several genetic diseases8 including Werner 
syndrome, lipoid proteinosis and autoimmune polyendocrine syndrome. It is seen 
in many systemic diseases like Hemochromatosis, Cushing syndrome, acromegaly 
and the various lipodystrophies(familial partial lipodystrophy, acquired partial 
lipoatrophy and HIV‐associated lipodystrophy) 
6) AUTOIMMUNE DISEASES 
Greater frequency of other autoimmune disorders86 include thyroid disease 
(more commonly hypothyroidism), coeliac disease (4–9%), vitiligo (4.5%), 
alopecia areata, Addison disease (0.5%) and the associated dermatological 
manifestations of those diseases (Dermatitis herpetiformis and Pretibial 
myxoedema). 
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Dawber et al87 found Vitiligo present in 4.8% of patients with adult onset diabetes, 
as compared with 0.7% to 1% of the general population. 
7) NAIL CHANGES88 
INFECTIONS - Acute paronychia, chronic paronychia and onychomycosis. 
VASCULAR LESIONS – Pterygium inversum unguis, pterygium, beau’s lines 
and onychohauxis.  
NEUROPATHY- Reflex sympathetic dystrophy, trauma 
MISCELLANEOUS – Rosenau’s depression, Leukonychia, Onychomadesis, 
Yellow nail syndrome, toe-nail thickening, abnormal curvature, hypertrophy of 
nail plate and ingrown toe nail. 
8) BULLOUS PEMPHIGOID89 
Bullous pemphigoid is associated with Type I diabetes mellitus. 20-40% of 
these patients have diabetes. Enzymatic glycosylation of glycoprotein at the 
lamina-lucida level acts as an antigen.  
9) PSORIASIS90 
The incidence observed is 2.4% but there is no convincing association is found 
between abnormal glucose tolerance test and surface area involvement by 
psoriasis.  
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10) LICHEN PLANUS91 
The prevalence of diabetes in patients with lichen planus varies from 1 to 
37%. The prevalence of oral lichen planus is found to be more in IDDM who 
smoke and those with history of candidiasis and they were of erosive type.  
11) MISCELLANEOUS DERMATOSES 
Macular amyloidosis, Cherry angioma and Eruptive syringomas are other 
associated dermatoses. There is indirect association between diabetes and both 
nephrogenic fibrosing dermopathy and calciphylaxis. 
TREATMENT RELATED SKIN MANIFESTATIONS 
1) INSULIN DYSTROPHY  
Both atrophy and hypertrophy may occur even with newer synthetic 
insulin. Insulin induced lipohypertrophy affected almost two‐thirds of patients and 
are more common in males. It is more common in patients who do not rotate the 
site of injection of insulin92 and can lead to impaired insulin absorption and poorer 
diabetic control. Lipoatrophy appears to be an immunological reaction [49]. The 
introduction of synthetic insulin has made it to 1-2%.93-95 Keloid and hypertrophic 
scar are found in prone diabetics.   
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2) ALLERGIC REACTIONS TO INSULIN  
Localized allergic reactions to insulin include urticaria94, painful nodules 
and granulomas. The use of an insulin pump may help, but contact dermatitis is 
reported.  
3) ALLERGIC REACTIONS TO ORAL HYPOGLYCEMIC DRUGS 
Sulphonylurea are the most common culprits, particularly a disulfiram like 
reaction to chlorpropamide. Photosensitivity, pruritus, erythema multiforme, 
erythema nodosum, urticaria, fixed drug eruption, lichenoid and morbilliform 
eruptions have all been described96. Among the new oral therapies, alpha 
glucosidase inhibitor Acarbose97 was recently reported to cause erythema 
multiforne after two weeks of therapy.   
 31 
AIMS AND OBJECTIVES 
1) To evaluate the prevalence of various skin disorders in patients with 
diabetes mellitus. 
2) To analyze the prevalence and pattern of skin disorders among diabetes 
mellitus patients in this tertiary care center in Chennai. 
3) To study the correlation between mean duration of diabetes mellitus and 
their skin manifestations. 
4) To compare the dermatoses in insulin dependent diabetes mellitus with 
those of non-insulin diabetes mellitus. 
5) To study about the treatment related skin manifestations. 
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MATERIALS AND METHODS 
1) Prospective observational study involving 200 consecutive patients either 
attending dermatology OPD with skin features related to diabetes or 
referred from diabetologydepartment. 
2) A detailed medical history pertaining diabetes was elicited in each patient 
with particular reference to the cutaneous complaints including duration, 
history of evolution and progression. 
3) An informed consent was taken from each patient, after which a general 
physical examination, systemic examination and a detailed dermatological 
examination carried out and the relevant details recorded and tabulated. 
4) Specific and non-specific skin findings related to diabetes mellitus was 
documented. 
5) Apart from routine laboratory investigations, F.B.S, P.P.B.S, Lipid profile 
for all cases. Bedside laboratory procedures like the Tzanck smear, KOH 
mount, and Gram's stain were carried out wherever needed. 
6) Skin biopsy was done in selected cases to confirm the diagnosis. 
7) Statistical analysis of various cutaneous findings was performed by 
appropriate statistical methods and inferences were drawn. 
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Inclusion criteria: 
1) All patients who attend dermatology op with skin findings suggestive of 
diabetes mellitus. 
2) All patients with known diabetes mellitus and skin manifestations referred 
from diabetology department. 
Exclusion criteria: 
1) Patients not willing for study. 
2) Those who having other associated endocrine diseases. 
ETHICAL ISSUES: 
Participants were made aware about the nature and purpose of the study. 
Willingness and signature of the participants were taken on a consent form.It was 
also informed to all that all the data provided by the patients will be kept 
confidential and will be used only for the study purpose. Written consents were 
obtained from all the subjects who participated in the study before the study was 
started. Institutional ethics committee of Madras medical college reviewed the 
study proposal for ethical consideration and approval.   
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STATISTICAL ANALYSIS:  
Data recorded was analyzed statistically by SPSS software. Using chi 
square test, prevalence and pattern of various cutaneous manifestations among 
diabetics was arrived. 
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OBSERVATIONS AND RESULTS 
Cutaneous manifestations found in our study are delineated according to 
classification by Huntley8 .In our study 72.5%(145) patients were NIDDM/Type 1 
DM and 55 patients (27.5%) were IDDM/Type 2 DM. We could not find any 
specific type of diabetes (pancreatic, hormonal, genetic, drug induced) or 
gestational diabetes with cutaneous manifestations in our study. 
AGE INCIDENCE: 
The age of patients found in IDDM ranged from 16 – 40 with the mean of 
27 years whereas the age in NIDDM patients ranged from 35 – 72 with the mean 
of 52 years. 
Table 1 : Comparison of age distribution among the two groups (n=200) 
Diabetes 
Mean 
Age 
Std. 
Deviation 
Mean 
difference 
p 
value 
95% confidence 
interval 
Type 1 DM 27.0 5.85 
-25.29 <0.001 -27.8 to -22.79 
Type 2 DM 52.3 8.68 
 
Comments: Subjects with Type 2 DM had a higher mean age than subjects 
with Type 1 DM and this difference in mean age was statistically significant. 
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Table 2 : Age distribution of the study population (n=200) 
Age group 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
<20 years 9 (16.4) 0 (0) 9 (4.5) 
21- 30 years 30 (54.5) 0 (0) 30 (15) 
31 – 40 years 16 (29.1) 11 (7.6) 27 (13.5) 
41 - 50 years 0 (0) 57 (39.3) 57 (28.5) 
51 - 60 years 0 (0) 50 (34.5) 50 (25) 
61 - 70 years 0 (0) 24 (16.6) 24 (12) 
>70 years 0 (0) 3 (2.1) 3 (1.5) 
Total 55 (100) 145 (100) 200 (100) 
 
Comments:  In type 1 DM, 54.5% fall under 21 – 30 years of age and in 
Type 2 DM, 39.3% under 41 – 50 years of age. 
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Chart 1 Age distribution of the study population (n=200) 
 
  
9
30
16
11
57
50
24
3
0
10
20
30
40
50
60
<20 21 to 30 
years
31 to 40 
years
41 to 50 
years
51 to 60 
years
61 to 70 
years
>70 years
T1DM T2DM
 38 
GENDER INCIDENCE : 
Out of 200 patients, 98 were males and 102 were females so male : female 
ratio is of 0.96:1.Thus slight female preponderance was noted in our study. Out of 
55 IDDM patients, 30(54.5%) were males and 25(45.5%) were females. Out of  
145 NIDDM patients,68(46.9%) were males and 77(53.1%) were females.  
Table 3 Gender Distribution of the study population (n=200) 
Gender 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Female 25 (45.5) 77 (53.1) 102 (51) 
Male 30 (54.5) 68 (46.9) 98 (49) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 0.934, p value: 0.334 
Comments: The difference in distribution of the study population according 
to gender was not statistically significant (p>0.05) between the groups. Hence both 
the groups are comparable. 
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Chart 2: Gender Distribution of the study population(n=200) 
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DURATION OF DIABETES : 
Mean duration of type 1 DM in our study was found to be around 5.2 years 
and in type 2 DM around 5.9 years. This difference in mean duration of disease 
was statistically significant. 
Table 4 Comparison of duration of Diabetes among the two groups (n=200) 
Diabetes 
Mean 
Duration 
Std. 
Deviation 
Mean 
difference 
p 
value 
95% confidence 
interval 
Type 1 5.207 5.4600 
-0.67 0.321 -2.01 to -0.66 
Type 2 5.883 3.7556 
 
Comments: Subjects with Type 2 DM had a higher mean duration of 
Diabetes than subjects with Type 1 DM and this difference in mean duration of 
disease was not statistically significant. 
Chart 3: Duration of Diabetes among the two groups (n=200) 
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CUTANEOUS INFECTIONS ; 
CANDIDIASIS:  
In our study candidiasis was prevalent in 56 patients (28%)of the patients. 
Tab 5  shows the prevalence of candidiasis is found to be 28.3% in NIDDM and 
27.3% in IDDM patients. Tab 6  shows In female patients of NIDDM vulvo-
vaginal candidiasis was found to be the most common type while male patients 
had balanoposthitis as frequent type of candidiasis. Type 1 DM patients were 
found to have oral thrush and balanoposthitis as the most common types. 
10% KOH wet mount examination of the scraping from the skin lesion 
showed blastospores and pseudohyphae in all the cases. 
Table 5 Distribution of candidiasis in the study population (n=200) 
Candidiasis 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 15 (27.3) 41 (28.3) 56 (28) 
Absent 40 (72.7) 104 (71.7) 144 (72) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 0.020, p value: 0.888 
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Comments: The difference in distribution of Candidiasis among the study 
population was not statistically significant (p>0.05) between the groups with 
candidiasis being common among Type 2 than Type 1 Diabetes. 
 
Chart 4 Distribution of candidiasis in the study population(n=200) 
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Table 6 Distribution of types of candida infections in the study population 
(n=56) 
Type of candidiasis 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Vulvovaginal 1 (6.7) 14 (34.1) 15 (26.8) 
Intertrigo 3 (20) 8 (19.5) 11 (19.6) 
Oral thrush 4 (26.7) 7 (17.1) 11 (19.6) 
Paronychia 2 (13.3) 3 (7.3) 5 (8.9) 
Balanoposthitis 4 (26.7) 9 (22) 13 (23.2) 
Angular cheilitis 1 (6.7) 0 (0) 1 (1.8) 
Total 15 (100) 41 (100) 56 (100) 
Chi-square value: 6.89, p value: 0.229 
Comments: The difference in distribution of different types of candida 
infections among the study population was not statistically significant (p>0.05). 
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Chart 5: Distribution of types of candida infections in the study 
population(n=56) 
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DERMATOPHYTE INFECTIONS : 
Among our study group totally 37 patients (18.5%) had dermatophyte 
infections. Prevalence in type 1 DM is 16.4% and type 2 is 19.3%. Tinea corporis 
is most common type in both IDDM and NIDDM. 3 patients in type 1 DM and 7 
patients in type 2 DM were found to have chronic dermatophytosis.4 patients in 
NIDDM were recurrent and refractory to treatment with systemic antifungals. No 
cases of Tinea capitis was found in our study. Wet mount examination of the skin 
lesions in 10% KOH showed long hyaline branching septate hyphae and 
arthrospores in almost the cases.  
Table 7 Distribution of dermatophytosis in the study population (n=200) 
Dermatophytosis 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 9 (16.4) 28 (19.3) 37 (18.5) 
Absent 46 (83.6) 117 (80.7) 163 (81.5) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 0.230, p value: 0.632 
Comments: The difference in distribution of Dermatophytosis among the 
study population was not statistically significant (p>0.05) between the groups with 
Dermatophytosis being common among Type 2 than Type 1 Diabetes.  
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Chart 6: Distribution of dermatophytosis(n=200) 
 
Table 8 Distribution of types of dermatophytosis in the study population 
(n=37) 
Dermatophytosis Type 1 DM N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Tinea corporis 4 (44.4) 14 (50) 18 (48.6) 
Tinea cruris 3 (33.3) 8 (28.6) 11 (29.7) 
Tinea pedis 2 (22.2) 6 (21.4) 8 (21.6) 
Total 9 (100) 28 (100) 37 (100) 
Chi-square value: 0.097, p value: 0.953 
Comments: The difference in distribution of different types of 
dermatophytosis among the study population was not statistically significant 
(p>0.05).   
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Chart 7: Types of dermatophytosis in the study population(n=37) 
 
PITYRIASIS VERSICOLOR  : 
Prevalence of Pityriasisversicolor was found to be 12.5% among our 
diabetic patients of which more commonly seen in type 1 DM(21.8%) than type 2 
DM (9%).Clinically they had well defined hypopigmented  macules and patches 
with branny scales distributed mainly seborrheic areas such as upper chest, back 
and face. Two of the patients were found to have perifollicular type and one had 
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recurrent type. Almost all patients were responded well to topical clotrimazole and 
single dose of fluconazole 400mg. 
KOH Wet mount of the scales showed hyaline short straight angulated 
hyphae with blastospores giving the appearance of sphaghetti and meatball. 
Table 9 Distribution of Tinea versicolor in the study population     (n=200) 
Tinea versicolor 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 12 (21.8) 13 (9) 25 (12.5) 
Absent 43 (78.2) 132 (91) 175 (87.5) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 6.022 , p value: 0.014 
Comments: The difference in distribution of Tinea versicolor among the 
study population was statistically significant (p<0.05) between the groups with 
Tinea versicolor being common among Type 1 than Type 2 Diabetes.  
MUCOR MYCOSIS  : 
Though rare, one case of rhinocerebral zygomycosiswere noted in our 
study. He presented with facial, eyelid edema, black eschar and palatal erosions. 
He had diabetes type 2 with duration of about 7 years with ketoacidosis. 
KOH Wet mount of eschar showed broad ribbon like and irregularly shaped 
non septate hyphae with branches at right angles. Culture showed greyish white 
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flat colonies with wooly texture adherent to plate surface. HPE and PAS stain 
showed broad ribbon like and irregularly shaped non  septate hyphae with 
branches at right angles. 
He was advised IV amphotericin B and surgical debridement. 
PRIMARY BACTERIAL INFECTIONS:  
Most common bacterial infection was observed to be furunculosis in our 
study with the prevalence of 10.5%. It was found to be more common in NIDDM 
patients. Other primary bacterial infections found were impetigo, folliculitis and 
abscesses. 
Gram stain of the discharge showed gram positive cocci arranged in groups 
and chains consistent with both staphylococcus and streptococcus. Out of 21 
patients four had recurrent furunculosis and MRSA growth on culture. 
Cellulitis due to deeper subcutaneous tissue involvement was found in  6 
patients(3%). NIDDM patients were found to be common in them with prevalence 
of  3.4% compared to IDDM patients(1.8%). Mean duration of diabetes was 6.5 
years. 
Two type 2 DM patients had erysipelas manifesting as tender erythematous 
edematous slightly elevated skin that spreads peripherally over lower limb. Both 
patient had 8 years duration of type 2 diabetes. Gram stain of the discharge 
showed streptococci and responded well to antibiotics.  
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Table 10 Distribution of Furunculosis in the study population (n=200) 
Furunculosis 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 4 (7.3) 17 (11.7) 21 (10.5) 
Absent 51 (92.7) 128 (88.3) 179 (89.5) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 8.41 , p value: 0.359 
Comments: Furunculosis was common among  Type 2 than Type 1 
Diabetes but this difference in distribution of Furunculosis among the study 
population was not statistically significant (p>0.05).  
 
Table 11 Distribution of Erysipelas in the study population (n=200) 
Erysipelas 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 0 (0) 2 (1.4) 2 (1) 
Absent 55 (100) 143 (98.6) 198 (99) 
Total 55 (100) 145 (100) 200 (100) 
 
Comments: Only 2 subjects were diagnosed with erysipelas among Type 2 
Diabetes and there was no case of erysipelas among the Type 1 diabetics.  
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CORYNEBACTERIAL INFECTIONS : 
Most common corynebacterial infection seen in our study was erythrasma 
(8%). Type 1 DM were found to have increased incidence (20%) than type 2 
(3.4%). It was found to be more in obese patients involving mainly over axilla and 
groin. Wood’s lamp examination showed coral red colour consistent with 
erythrasma. 
Next common corynebacterial infection observed in our study was 
keratolysis punctate manifesting as pits over palms, soles and dorsum of hands. 
Prevalence was found to be 2% of the total study group with type 1 DM (3.6%) 
more than type 2 (1.4%). It was found more in females who were homemakers. 
Trichomycosis axillaris was not found in our study. 
Table 12 Distribution of Erythrasma in the study population (n=200) 
Erythrasma Type 1 DM N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 11 (20) 5 (3.4) 16 (8) 
Absent 44 (80) 140 (96.6) 184 (92) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 12.67 , p value: <0.001 
Comments: The difference in distribution of Erythrasma among the study 
population was statistically significant (p<0.05) between the groups with 
Erythrasma being common among Type 1 than Type 2 Diabetes.   
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Table 13 Distribution of Keratolysis punctata in the study population (n=200) 
Keratolysis punctata 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 2 (3.6) 2 (1.4) 4 (2) 
Absent 53 (96.4) 143 (98.6) 196 (98) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 1.036 , p value: 0.309 
Comments: Keratolysis punctata was common among Type 1 than Type 2 
Diabetes but this difference in distribution of Keratolysis punctata was not 
statistically significant (p>0.05).  
 
Chart 8: Distribution of various bacterial infections (n=200) 
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VIRAL INFECTIONS : 
Among the 3 subjects diagnosed with viral infections in Type 2 Diabetes, 2 
subjects had herpe zoster and 1 subject had Verucca while only 1 case herpes 
zoster was reported among the Type 1 diabetics. 
Tzanck smear from zoster lesion showed multinucleated giant cell. 
Table 14 Distribution of viral infections in the study population (n=200) 
Viral infections 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 1 (1.8) 3 (2.1) 4 (2) 
Absent 54 (98.2) 142 (97.9) 196 (98) 
Total 55 (100) 145 (100) 200 (100) 
p value: 0.910 
Comments: Only 3 subjects were diagnosed with viral infections among 
Type 2 Diabetes while only 1 case reported with viral infection among the Type 1 
diabetics and this difference was not statistically significant (p>0.05).  
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Table 15 Distribution of type of viral infections in the study population (n=4) 
Viral infections 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Herpes Zoster 1 (100) 2 (66.7) 3 (75) 
Verucca 0 (0) 1 (33.3) 1 (25) 
Total 1 (100) 3 (100) 4 (100) 
 
Table 16 Distribution of Cutaneous infections in the study population (n=200) 
Cutaneous 
infections Type 
Type 1 DM 
N (%) 
Type 2 
DM 
N (%) 
Total 
N (%) 
Fungal 
Candidiasis 15 (27.3) 41 (28.3) 56 (28) 
Dermatophytosis 9 (16.4) 28 (19.3) 37 (18.5) 
TineaVersicolor 12 (21.8) 13 (9) 25 (12.5) 
Mucormycosis 0 (0) 1 (0.7) 1 (0.5) 
Bacterial 
Erythrasma 11 (20) 5 (3.4) 16 (8) 
Furunculosis 4 (7.3) 17 (11.7) 21 (10.5) 
Keratolysispunctata 2 (3.6) 2 (1.4) 4 (2) 
Erysipelas 0 (0) 2 (1.4) 2 (1) 
Cellulitis 1 (1.8) 5 (3.4) 6 (3) 
Viral Herpes Zoster & Verruca 1 (1.8) 3 (2.1) 4 (2) 
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Chart 9: Distribution of various infections(n=200) 
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MANIFESTATIONS DUE TO VASCULAR DAMAGE : 
LEG ULCERS: 
Only 4 subjects were diagnosed with Leg ulcers among Type 1 Diabetes 
while 10 cases reported with Leg ulcers among the Type 2 diabetics. Four out of 
ten type 1 diabetes patients with leg ulcers had neuropathy either motor or sensory 
contributing to the causation of ulcers. Mean duration of type 2 DM was found to 
be 10 years with poor control of metabolic state. 
Multidisciplinary approach in form of orthopedic, vascular surgery and 
good nursing care were given to rule out vascular and bone involvement in the 
ulcer. 
Table 17 Distribution of Leg ulcers in the study population (n=200) 
Leg ulcers 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 4 (7.3) 10 (6.9) 14 (7) 
Absent 51 (92.7) 135 (93.1) 186 (93) 
Total 55 (100) 145 (100) 200 (100) 
p value: 0.926 
Comments: Only 4 subjects were diagnosed with Leg ulcers among Type 1 
Diabetes while 10 cases reported with Leg ulcers among the Type 2 diabetics but 
this difference was not statistically significant (p>0.05).  
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GANGRENE : 
Gangrene of the foot indicating late manifestation of microangiopathy was 
reported in one type 2 diabetes patient. He was advised surgical debridement and 
was referred to surgery department. 
DIABETIC DERMOPATHY : 
One case of diabetic dermopathy manifesting as small, atrophic 
hyperpigmented irregular patches on the anterior shins. History of trauma was 
present. 
NAIL CHANGES : 
Paronychia was present in 5 (8.9%) patients of which IDDM was 11.5% 
and NIDDM was 6.7%. It presented as both acute and chronic painful swelling of 
proximal nail fold with discharge of pus and loss of cuticle. More commonly seen 
in patients who do household works. One patient was found to have greenish 
discoloration of nail fold suggestive of pseudomonas infection. 
Pterygium was found in two of type 2 diabetes patients and leukonychia in three of 
type 2 diabetes patients. 
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Table 18 Distribution of lesions due to vascular damage in the study 
population (n=200) 
 
Vascular 
damage 
Type 
Type 1 DM 
N (%) 
Type 2 
DM 
N (%) 
Total 
N (%) 
M
ic
ro
- a
ng
io
pa
th
y 
Wet Gangrene 0 (0) 1 (0.7) 1 (0.5) 
N
ai
l c
ha
ng
es
 
Beau line 1 (1.8) 1 (0.7) 2 (1) 
Pterygium 0 (0) 2 (1.4) 2 (1) 
Leg Ulcer 4 (7.3) 10 (6.9) 14 (7) 
Diabetic Dermopathy 0 (0) 1 (0.7) 1 (0.5) 
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Chart 10: Distribution of lesions due to vascular damage (n=200)  
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NEUROLOGICAL DAMAGE: 
Neuropathy was observed to be 33% of total study population more 
common in IDDM (45.5%) than NIDDM (28.3%). Motor  neuropathy 
characterized by hammer toes was observed in one type 2 diabetes individual. 
Autonomic neuropathy manifested as fissures over soles, callus, xerosis over legs. 
both sensory and autonomic neuropathy was reported in 4 patients. 
Table 19 Distribution of types of Neuropathy in the study population (n=66) 
Neuropathy Type 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Autonomic 3 (12) 7 (17.1) 10 (15.2) 
Motor 0 (0) 1 (2.4) 1 (1.5) 
Sensory 19 (76) 32 (78) 51 (77.3) 
Autonomic + Sensory 3 (12) 1 (2.4) 4 (6.1) 
Total 25 (100) 41 (100) 66 (100) 
Chi-square value: 3.224 ,  p value: 0.358 
Comments: Sensory Neuropathy was the most commonest in both Type 1 
and Type 2 Diabetes and the difference in distribution of neuropathy was not 
statistically significant (p>0.05). 
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Table 20 Distribution of neuropathy lesions in the study population (n=200) 
Neuropathy 
Type 
Type 1 DM 
N (%) 
Type 2 
DM 
N (%) 
Total 
N (%) 
Autonomic 3 (5.5) 7 (4.8) 10 (5) 
Motor 0 (0) 1 (0.7) 1 (0.5) 
Sensory 19 (34.5) 32 (22.1) 51 (25.5) 
Autonomic + Sensory 3 (5.5) 1 (0.7) 4 (6.1) 
 
Chart 11: Distribution of neuropathy lesions (n=200) 
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Table 21 Distribution of Neuropathy in the study population (n=200) 
Neuropathy 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 25 (45.5) 41 (28.3) 66 (33) 
Absent 30 (54.5) 104 (71.7) 134 (67) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 5.322 ,  p value: 0.021 
Comments: Neuropathy was common among  Type 1 than Type 2 Diabetes 
and this difference in distribution of neuropathy was statistically significant 
(p<0.05).  
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OBESITY AND HYPERLIPIDEMIA RELATED SKIN DISEASES : 
ACANTHOSIS NIGRICANS : 
As a marker of insulin resistance acanthosis nigricans was seen 
predominantly in type 2 diabetes (6.3%) than type 1 diabetes patients ( 7.2%) 
Table 22 Distribution of Acanthosis nigricans in the study population (n=200) 
Acanthosis nigricans 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 3 (6.3) 10 (7.2) 13 (6.5) 
Absent 51 (92.7) 136 (93.8) 187 (93.5) 
Total 55 (100) 145 (100) 200 (100) 
p value: 0.785 
Comments: Only 3 subjects were diagnosed with Acanthosis nigricans 
among Type 1 Diabetes while 10 cases reported with Acanthosis nigricans among 
the Type 2 diabetics but this difference was not statistically significant (p>0.05).  
  
 64 
Table 23 Distribution of Acrochordon in the study population (n=200) 
Acrochordon 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Present 11 (20) 15 (10.3) 26 (13) 
Absent 44 (80) 130 (89.7) 174 (87) 
Total 55 (100) 145 (100) 200 (100) 
p value: 0.070 
Comments: Acrochordon was common among  Type 1 than Type 2 
Diabetes but this difference in distribution of acrochordon was not statistically 
significant (p>0.05).  
XANTHELASMA : 
Three of NIDDM patients were found to have xantheslasma presenting as 
yellowish plaques over upper eyelid. Two of the three patient had abnormal lipid 
levels. 
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Table 24 Distribution of Obesity and hyperlipidemia lesions in the study 
population      (n=200) 
Lesion 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Acanthosisnigricans 4 (7.3) 9 (6.2) 13 (6.5) 
Acrochordon 11 (20) 15 (10.3) 26 (13) 
Xanthelesma 0 (0) 3 (2.1) 3 (1.5) 
 
Chart 12: Distribution of Obesity and hyperlipidemia lesions (n=200) 
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GRANULOMATOUS SKIN DISORDERS : 
Three cases of granuloma annulare two in type 2  diabetes group and one in 
the other. One case in IDDM and one case in NIDDM were generalized type of 
GA. Histopathological examination of the lesion showed interstitial type of 
necrobiotic granuloma in upper and mid dermis. One NLD case was seen in our 
study which was consistent with the histopathological findings.  
Table 25 Distribution of granulomatous disorders in the study population 
(n=200) 
Granulomatous disorders 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Granuloma annulare 1 (1.8) 2 (1.4) 3 (1.5) 
Necrobiosis lipoidica 0 (0) 1(0.7) 1(0.5) 
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STIFF SKIN AND JOINTS : 
Cheiroarthropathy characterized by waxy tight skin on the backs of the 
hands and limited joint mobility (‘prayer sign’) was seen in both type 1 and 2 
diabetes individuals. It is a measure of underlying microvascular changes 
neuropathy and retinopathy. It is demonstrated by inability to approximate the two 
palms with hands pressed together and fingers separated in extension called the 
“PRAYER SIGN” .  Finger pebbles was not seen in our study group. 
Scleredema diabeticorum characterized  by ill defined induration of the skin on the 
neck and upper back was seen in two of NIDDM patients with mean duration of 
diabetes around 19 years. 
Table 26 Distribution of stiff skin & joint disorders in the study population 
(n=200)9 
stiff skin & joint disorders Type 1 DM N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Cheiroarthropathy 1 (1.8) 1 (0.7) 2 (1) 
Scleredema diabeticorum 0 (0) 2 (1.4) 2 (1) 
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DERMATOSES ASSOCIATED WITH DIABETES 
PRURITUS: 
Pruritus was seen in 11% of our study population. Truncal pruritus in 
association with autonomic neuropathy were found in 12 patients thus was found 
in 6% of our study. Other systemic diseases were ruled out. Anogenital pruritus 
were found be in prevalence of  3.4% in type 2 and 9.1% in type 1. 
Table 27 Distribution of Pruritus in the study population (n=200) 
Pruritus 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Anogenital 5 (9.1) 5 (3.4) 10 (5) 
Truncal 4 (7.3)  8 (5.5) 12 (6) 
Absent 46 (83.6) 132 (91) 178 (89) 
Total 55 (100) 145 (100) 200 (100) 
Chi-square value: 2.989 ,  p value: 0.224 
Comments: Pruritus was common among  Type 1 than Type 2 Diabetes but 
this  difference in distribution of Pruritus was not statistically significant (p>0.05).   
 69 
 
Table 28 Distribution of other skin lesions frequently associated with Diabetes 
in the study population (n=200) 
skin lesions 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Vitiligo 7 (12.7) 4 (2.8) 11 (5.5) 
Psoriasis 0 (0) 6 (4.1) 6 (3) 
Lichen Planus 2 (3.6) 1 (0.7) 3 (1.5) 
Pretibial myxedema 0 (0) 1 (0.7) 1 (0.5) 
Perforating dermatoses 0 (0) 1 (0.7) 1 (0.5) 
Macular amyloidosis 1 (1.8) 2 (1.4) 3 (1.5) 
Lichen amyloidosis 0 (0) 1 (0.7) 1 (0.5) 
Diabetic bulla 1 (1.8) 3 (2.1) 4 (2) 
Cherry angiomas 0 (0) 2 (1.4) 2 (1) 
Bullous pemphigoid 0 (0) 1 (0.7) 1 (0.5) 
Associated 
Nail changes 
Leukonychia 0 (0) 3 (2.1) 3 (1.5) 
Plate thickening 0 (0) 1 (0.7) 1 (0.5) 
Onychomadesis 0 (0) 1 (0.7) 1 (0.5) 
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TREATMENT RELATED SKIN DISORDERS : 
Insulin induced lipoatrophy and keloid were found more common than 
OHA related drug reactions. 
Table 29 Distribution of treatment related skin disorders in the study 
population   (n=200) 
Treatment Type Type 1 DM N (%) 
Type 2 
DM 
N (%) 
Total 
N (%) 
Insulin 
Lipoatrophy 1 (1.8) 1 (0.7) 2 (1) 
Keloid 2 (3.6) 0 (0) 2 (1) 
OHA 
Photosensitivity 0 (0) 1 (0.7) 1 (0.5) 
Fixed drug eruptions 0 (0) 1 (0.7) 1 (0.5) 
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Chart 13: Treatment related skin disorders in the study population (n=200) 
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Table 30 Distribution of skin lesions in various categories in the study 
population (n=200) 
Skin lesions 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Infection 41 (74.5) 100 (69) 141 (70.5) 
Lesions due to Vascular damage 5 (9.1) 14 (9.7) 19 (9.5) 
Neuropathy 25 (45.5) 41 (28.3) 66 (33) 
Hyperlipidemia associated 
lesions 
12 (21.8) 19 (13.1) 31 (15.5) 
Granulomatous skin lesions 1 (1.8) 3 (2.1) 4 (2) 
Stiff skin & Joints 1 (1.8) 3 (2.1) 4 (2) 
Treatment related lesions 3 (5.5) 3(2.1) 6 (3) 
Skin lesions associated with 
diabetes 
21 (38.2) 41 (28.3) 62 (31) 
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Chart 14: Distribution of skin lesions in various categories (n=200) 
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Chart 15: Distribution of skin lesions in various categories (n=200) 
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Table 31 Distribution of study population according to number of skin lesions 
(n=200) 
Skin lesions 
Type 1 DM 
N (%) 
Type 2 DM 
N (%) 
Total 
N (%) 
Absent 1 (1.8) 1 (0.7) 2 (1) 
One lesion 13 (23.6) 73 (50.3) 86 (43) 
Two lesions 26 (47.3) 63 (43.4) 89 (44.5) 
Three lesions 15 (27.3) 8 (5.5) 23 (11.5) 
Total 55 (100) 145 (100) 200 (100) 
 
More than one lesion / dermatoses was found in 56% of our study 
population. 
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Chart 16: Number of skin lesions per patient (n=200) 
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Table 32 Relationship between duration of Diabetes and occurrence of 
infection (n=200) 
Infection Mean Duration 
Std. 
Deviation p value 
95% confidence 
interval 
Present 6.500 4.5152 
<0.001 1.46 to 3.98 
Absent 3.778 2.9263 
 
Comments: Subjects with infection had a higher mean duration of Diabetes 
than subjects without infection and this difference in mean duration of disease was 
statistically significant. 
 
Table 33 Relationship between duration of Diabetes and occurrence of 
Lesions due to vascular damage (n=200) 
Vascular damage Mean Duration 
Std. 
Deviation p value 
95% confidence 
interval 
Present 7.763 5.6969 
0.027 0.263 to 4.302 
Absent 5.480 4.0725 
Comments: Subjects with vascular damage had a higher mean duration of 
Diabetes than subjects without vascular damage and this difference in mean 
duration of disease was statistically significant.  
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Table 34 Relationship between duration of Diabetes and occurrence of 
Lesions due to neuropathy (n=200) 
Neuropathy Mean Duration 
Std. 
Deviation p value 
95% confidence 
interval 
Present 7.229 5.0095 
<0.001 1.052 to 3.519 
Absent 4.943 3.6757 
 
Comments: Subjects with Neuropathy had a higher mean duration of 
Diabetes than subjects without Neuropathy and this difference in mean duration of 
disease was statistically significant. 
Table 35 Correlation between duration of Diabetes and Number of skin 
Lesions (n=200) 
Number of lesions N Mean Std.deviation 
0 2 0.500 0.7071 
1 86 4.996 3.6264 
2 89 5.957 4.2248 
3 23 7.765 5.9137 
Total 200 5.697 4.2881 
Pearson’s correlation: 0.219 p value: 0.001 
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Comments: There was a positive linear relationship between number of 
lesions and mean duration of Diabetes as found by pearson’s correlation. Hence as 
the duration of Diabetes increases, the number of skin lesions will also tend to rise. 
Chart 17: Correlation between duration of Diabetes and Number of skin 
Lesions (n=200) 
 
  
Colour Plates 
Figure 1: Tinea facieii 
 
Figure 2: KOH Wet mount of Dermatophyte shows long hyaline branched 
septate hyphae with arthrospores 
 
  
Figure 3: Oral Candidiasis 
 
Figure 4: Gram stain shows budding yeast cells and blastospores 
 
  
  
Figure 5: KOH Wet mount of Pityriasis versicolor shows short straight 
angulated hyphae with blastospores 
 
Figure 6: MUCOR MYCOSIS 
 
  
  
Figure 7: KOH Wet mount shows broad ribbon like non septate hyphae with 
branches at right angle s/o Mucor mycosis 
 
Figure 8: Culture shows grayish white flat colonies with wooly texture 
 
  
  
Figure 9: HPE shows broad ribbon like non septate hyphae 
 
Figure 10: Cellulitis  
 
  
Figure 11: Erysipelas  
 
Figure 12: Keratolysis punctata 
 
  
  
Figure 13: Herpes zoster 
 
Figure 14: Tzanck smear showing multinucleated giant cell 
 
  
  
Figure 15: Verucca vulgaris 
 
Figure 16: HPE of Verucca  
 
  
  
Figure 17: Trophic ulcer with distally displaced plantar fat pads 
 
Figure 18: Hammer toes 
 
  
  
Figure 19: Acanthosis nigricans with multiple skin tags 
 
Figure 20: HPE of Acanthosis nigricans 
 
  
  
Figure 21: Xanthelasma 
 
  
  
Figure 22: Granuloma annulare 
 
Figure 23: HPE of Granuloma annulare 
 
  
  
Figure 24: Necrobiosis lipoidica 
 
Figure 25: HPE of Necrobiosis lipoidica shows sclerosis and infiltrate in 
upper and mid dermis 
 
  
  
Figure 26: Cheiroarthropathy 
 
Figure 27: Scleredema diabeticorum 
 
  
Figure 28: Diabetic bulla 
 
Figure 29: HPE of Diabetic bulla 
 
  
  
Figure 30: Perforating folliculitis 
 
Figure 31: HPE of Perforating folliculitis 
 
  
  
Figure 32: Vitiligo 
 
Figure 33: Alopecia areata 
 
  
  
Figure 34: Oral lichen planus 
 
Figure 35: Pretibial myxedema 
 
  
  
Figure 36: Keloid 
 
Figure 37: Fixed drug eruption 
 
  
Figure 38: Beau’s lines 
 
Figure 39: Diabetic dermopathy 
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DISCUSSION 
This study was conducted in the outpatient clinics of Department of 
Dermatology and Institute of Diabetology at Rajiv Gandhi Government General 
Hospital, Chennai. Diabetes mellitus is the most common metabolic disorder in 
which skin is the most unique organ to be involved. 
AGE DISTRIBUTION 
Type 1 DM is usually seen in cases less than 30 years of age and occurs 
mostly in children and the incidence is highest among the 10 to 14 years old age 
groups, whereas type 2 DM has a gradual onset and occurs mainly in the middle-
aged and elderly101. 
In our study Type 1 Diabetes was commonly found in a younger age group 
of 21 to 30 years (54.5%) whereas Type 2 Diabetes was commonly seen in middle 
age group 41 to 50 years (39.3%). In both types 41 to 50 years(28.5%) is the most 
common age group seen which is comparable to Bhat et al.,100Mahajan et al.,98and 
Roshini vahora et al102 where they found that the most common age group to be of 
41 - 50 years in 33.3%, 33%, 40% of the patients respectively in their studies. 
GENDER INCIDENCE: 
In our study females show slight predominance over males (51% and 49%) 
and is correlating with the previous studies done by Mahajan98 et al study in which 
females show preponderance over males (58% and 42%) and it is not correlating 
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with Abhisheck goel et al103 (46% and 54%) and Roshini vahora et al102  (49% and 
51%) 
INCIDENCE: 
Most studies have shown the incidence of cutaneous disorders associated 
with diabetes to be between 30% and 71%.1,2 Mahajan et al98 in  their study found 
that 64% of patients had cutaneous manifestations. Nigam and Pande99 in a study 
on the pattern of dermatoses in 200 diabetics found that 61% had cutaneous 
dermatoses. Bhat et al100in a study of the cutaneous manifestation of diabetes 
mellitus in 150 diabetics found it to be in 66% of the cases and 21.3% of the 
controls.  
TYPE OF DIABETES :  
Our study comprising of 200 diabetics,145 patients (72.5%) were NIDDM 
and 55 patients (27.5%) were IDDM differ from the study made by Mahajan et al98 
and Bhat et al100 where they had type 2 DM in 98% and 97.7% respectively. In our 
study we could not find any secondary diabetes or gestational diabetes patients as 
in Mahajan et al98 and Bhat et al100 
DURATION: 
Most of the patients in the study of Bhat100 et al and Ahmed104et al had 
mean duration of DM about 10 years in most of their patients. Our study showed 
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duration of about 5.2 years in IDDM and 5.9 years in NIDDM as mean duration 
which is also statistically significant. 
NUMBER OF SKIN LESIONS/DISORDERS :  
56% of patients show more than one lesion in present study which is 
correlating with the study done by Roshini et al102 (44%) and differs from 
Abhisheck goel et al(80%)103 
CUTANEOUS INFECTIONS : 
Cutaneous infections occur in 70.5% of patients in our study. This is similar 
to the observation done by Naheed et al105 (62.2%) of diabetics, Mahajan et al98 
(54.69%) and Baloch106et al (72% )  
Fungal Infections :   
In our study we found fungal infections were most common(59.5%) out of 
which candidiasis(28%) as the most common fungal infections. This is in 
concordance with Mahajan et al98where fungal infections constitutes 59% out of 
which candidiasis(30.4%) is the most frequent infections. Vulvovaginal 
candidiasis was most seen type in females while males had balanoposthitis as 
common type. We found that three female patients and one male patient in type 2 
DM who presented with candidiasis while screening found to be diabetic. 
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Second most common infection was found to be dermatophytosis(18.5%) 
which is somewhat equal to studies by manish et al107(14%) 
Bacterial Infections :  
We observed in our study bacterial infections(24.5%) as the next common 
infection. This is found to be in less prevalence than in Mahajan et al98(34%) and 
Rao et al(36%)108.  
We noted that erythrasma(8%) was the next common bacterial infection. 
This is same as that of observations made by Rao et al.108 (6%) 
MANIFESTATIONS DUE TO VASCULAR CHANGES :  
In our study we found that 7% of diabetics had leg ulcer as the most 
common lesion due to vascular damage. Leg ulcer(7%) was found to be common 
in type 1 DM which is more when compared to Rao et al(3%)108 and less than 
Nigam et al99(12.9%) 
Diabetic dermopathy was seen in 3% by Nigam and Pande et al99, in 7% by 
Mahajan et al98 in 4.2% by Ahmed et al.,104and 11.3% by Bhat et al100.In our study  
we found only one case diabetic dermopathy(0.5%) which is very much less than 
the above studies.  
Sudden loss of perfusion in a already compromised microcirculation results 
in wet gangrene of  the foot. In our study we found a 44 year male patient with 
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gangrene of the foot (0.5%) in type 2 DM group who had duration of about 3 
years. This percentage is found to be less when compared to Rao et al (2%)108 
We could find nail changes such as beau’s lines and pterygium in 2% of our 
study population. 
Rubeosis has been reported in 3 - 59% of the diabetics11. But in our study 
we could not find any patients with rubeosis probably due to the dark skin of 
Indians.  
NEUROLOGICAL CHANGES : 
Neuropathy  was observed in 45.5% among IDDM and 28.3% among 
NIDDDM thus  in total around 33% patients in this study population which is 
close to 35 – 62% in previous studies110. It is more when compared to Mahajan  
et al98(12.5%). The sensory neuropathy (77.3%) was noted to be in common in 
both type of diabetes.  
OBESITY AND HYPERLIPIDEMIA RELATED SKIN DISEASES : 
Acanthosis nigricans and acrochordons are established cutaneous markers 
of diabetes.8 We observed acrochordons in 13% of study population which is in 
concordance to Nigam et al99(12.3%) but less when compared to Abhishek et 
al(32%)103 
Acanthosis nigricans is usually seen in insulin resistance situations such as 
type 2 DM, obesity, and total lipodystrophy.111 We noted acanthosis nigricans in 
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6.5% of our patients which is equal to 5.3%  in Bhat et al 100 , 4.7% in Mutairi et 
al.,111  but less when compared to 3% in Mahajan et al98and 2.8% in Ahmed et 
al.104  
Xanthelasma was observed in 1.5% of study population. This is similar to 
Nigam et al99and Ahmed et al104 study. 
GRANULOMATOUS DISORDERS : 
Granuloma annulare was observed in 1.5% of our study population. It is a 
necrobiotic disorder 11 usually seen in children and young adults.8 Though the 
association of granuloma annulare with diabetes is not clear11 various studies show 
40% of generalized GA is associated with Diabetes mellitus. 
Necrobiosis lipoidica (NL) is  also a necrobiotic disorder106  found in the 
legs as the primary site. When NL is seen in other areas than the lower legs, the 
patient is less likely to have diabetes mellitus.8 Nerobiosis lipoidica occurs in 0.3-
1.6% of diabetics, but can occur in non-diabetic conditions also.8 In our study, 
NLD was seen in one patient(0.5%) in type 2 diabetes group with the duration of 
diabetes about 7 years which is similar to the findings made by Foss et al112 and 
Nigam et al.99 
As granuloma annulare, and necrobiosis lipoidica were observed only in a few 
cases, the association between these diseases and diabetes could not be ascertained 
in this study. 
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STIFF SKIN AND JOINTS : 
In our present study we noted two cases of each in cheiroarthropathy and 
scleredema diabeticorum. Thus we are found each of them in 1% of our study. 
This is very similar to the studies done by Mahajan et al98(0.9%) 
DERMATOSES ASSOCIATED WITH DIABETES : 
Associated dermatoses was found in 20% of our study population of which 
pruritus was present in 11% of our study. Truncal pruritus was seen in 6% and 
anogenital pruritus in 5%. Generalized pruritus is not specifically associated with 
diabetes mellitus, although pruritus vulvae may be the presenting symptoms of 
diabetes.109 Pruritus was reported in 15.6% of the diabetics by Mahajan et al98and 
in 4.5% by Nigam and Pande.99 
Bullous diabeticorum or idiopathic bullae of diabetes are distinct markers 
of diabetes. It is seen in 2% of our study as exactly seen in Abhishek et al103 and 
more when compared to Nigam et al99 (1%) and Ahmed et al(0.6%)104 
Vitiligo and psoriasis were present in 5.5% and 3% of our study of which 
vitiligo seen more in IDDM patients which is same as that of Ahmed et al(5.5%)104 
and Foss et al(2.5%)112. We found only one case of each in perforating 
dermatoses, pretibial myxedema, bullous pemphigoid. Their association with 
diabetes could not be ascertained. The patient who had perforating folliculitis was 
also found to have diabetic nephropathy.   
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TREATMENT RELATED SKIN DISORDERS : 
Cutaneous complications of diabetes therapy was observed in 3% of our 
study group.  Adverse reactions to insulin in form of lipoatrophy and keloid were 
observed in only 2% of all patients treated with insulin. Photosensitivity and FDE 
to OHA were found in 1% of our study group. This is less when compared to 
Mahajan et al.98 (3%)  
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LIMITATIONS OF THE STUDY : 
1. As this study has been carried out over a limited period of time it was not 
large enough to be of reasonable precision.  
2. It is a hospital based study the frequency of cutaneous manifestations may 
not reflect the actual population of our community. 
3. Few dermatoses that were found to be more associated in diabetes in 
various studies cannot be ascertained as they were observed in only a few 
number in our study. 
4. Secondary and gestational diabetes with cutaneous features was not found 
in our study which hinders to know the exact prevalence of dermatoses in 
diabetes in our area. 
5. Investigations such as HbA1c, antibody testing which improves the 
specificity of diagnosing diabetes could not be done in our hospital due to 
resource constraints. 
6. Histopathological examination of skin conditions were done only in lesions 
with diagnostic ambiguity.   
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STRENGTH OF THE STUDY: 
Study population was 200 which is large enough to know the prevalence of skin 
manifestations in our community to a certain extent.  
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CONCLUSION: 
In a prospective observational study consisting of 200 diabetics with 
cutaneous features attending our hospital RGGGH, Chennai we found that, 
 Most of the dermatoses associated with diabetes were found in age group of 
41 to 50 years of age.  
 In our study comprising of 200 diabetics,145 patients (72.5%) were 
NIDDM and 55 patients (27.5%) and females show slight predominance 
over males (49% and 51%) 
 Mean duration was found to be of about 5.2  years in IDDM and 5.9 years 
in NIDDM.  
 As the duration of diabetes increases the number of dermatoses/lesions, co-
morbidities and complications were also found to increase. 
 Infections, neuropathy, pruritus and associated dermatoses were observed 
to be the common dermatoses in the same order. 
 Cutaneous infections formed the largest group in our study correlating in 
almost all various studies. 
 Among infections fungal infections are the most common infection. 
Candidiasis is found to be the early marker of undiagnosed diabetes. 
 Vulvovaginal candidiasis was most seen type in females while males had 
balanoposthitis as common type. 
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 Totally around 33% patients in this study population was noted to have 
neuropathy and sensory neuropathy. (77.3%) that was noted to be in 
common in both type of diabetes.  
 Acrochordon is found to be the most common obesity/ hyperlipidemia 
related disorders. 
 Among granulomatous disorders, granuloma annulare(1.5%) was noted to 
be the most common. 
 In dermatoses associated with diabetes we observed pruritus (11%) as the 
most common one. 
 Vitiligo, Oral lichen planus, Acanthosis nigricans, Granuloma annulare 
were seen exclusively in IDDM group. Psoriasis, Acrochordons, Localized 
cutaneous amyloidosis were limited more to the NIDDM group.  
 Thus emphasizing the importance of the physicians to be made aware of 
cutaneous manifestations in diabetes mellitus where the ignorance of skin 
manifestations in diabetes or improper treatment may make the condition 
worse. 
 The early detection and early treatment of common skin manifestations in 
diabetes will prevent further complications or ineffectiveness due to 
treatment which will help these patients to lead a normal life.
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PROFORMA 
NAME:                                                                AGE / SEX: 
OP/IP No:                                                           OCCUPATION: 
ADDRESS: 
TYPE OF DIABETES : 
DURATION OF DIABETES : 
TYPE OF TREATMENT:  
HISTORY OF : 
TRUNCAL/ANOGENITAL PRURITUS  
VAGINAL DISCHARGE 
PHIMOSIS/BALANOPOSTHITIS 
RECURRENT FUNGAL 
INFECTIONS(TINEA,CANDIDA,PARONYCHIA) 
RECURRENT BACTERIAL INFECTIONS(INCLUDING 
PSEUDOMONAS) 
VASCULAR LESIONS LIKE GANGRENE 
NEUROPATHY,TROPHIC ULCER 
DECREASED SWEATING OFLEGS,CORNS,CALLOSITIES,FISSURES 
SKIN LESIONS-FLESHY GROWTH,PIGMENTATIONS IN FLEXURES 
                            RAISED LESIONS DISCHARGING KERATINOUS 
PLUG  
                            DULL RED SCALY PAPULES/SCARS IN 
EXTREMITIES                                                           
ERYTHEMA,SWELLING OF FACE,HAND,FEET 
INDURATION OF BACK,NECK 
DEFORMITY OF FOOT 
WEIGHT GAIN 
AUTOIMMUNE DISEASES 
  
GENETIC DISEASES 
TREATMENT RELATED COMPLICATIONS 
TREATMENT HISTORY: 
 
PAST HISTORY: 
H/O PREVIOUS DIABETES STATUS 
H/O CHRONIC SYSTEMIC ILLNESS 
 
PERSONAL HISTORY : 
 TYPE OF DIET 
 
GENERALEXAMINATION :           PALLOR                   ICTERUS                     
CLUBBING         CYANOSIS            PEDAL EDEMA       
LYMPHADENOPATHY 
WEIGHT(BMI) 
 
SYSTEMIC PULSE                                BP                                                                     
   CVS RS 
 P/A                                    CNS 
 
DERMATOLOGICAL EXAMINATION: 
TRUNK          :ERYTHEMA,YELLOW DISCOLORATION 
XEROSIS 
            INDURATION/SCLEREDEMA 
FACE                      :RUBEOSIS 
FLEXURES            :ACANTHOSIS NIGRICANS,SKIN TAGS,INTERTRIGO 
EXTREMITIES     :XEROSIS 
                                            ERYTHEMA,EDEMA,ATROPHY 
                                            DIABETIC DERMOPATHY 
  
                                            SENSORY NEUROPATHY 
                                            AUTONOMIC NEUROPATHY 
                                            DIABETIC FOOT 
                                            DIABETIC ULCER/GANGRENE 
                                            RUBEOSIS 
                                            ERYSIPELAS/CELLULITUS 
                                            FINGER PEBBLES 
                                            DIABETIC BULLAE 
                                            DIABETIC CHEIROARTHROPATHY 
                                            DEFORMITIES 
NAIL                          :PARONYCHIA-ACUTE,CHRONIC 
                                                            YELLOW NAIL 
                                                            ONYCHOMYCOSIS 
                                                            PSEUDOMONAS NAIL INFECTION 
ORALMUCOSA                :THRUSH,CANDIDIASIS 
 
GENITALS                          :VULVOVAGINITIS 
BALANOPOSTHITIS 
                                                            PHIMOSIS 
 
INFECTIONS                      : 
BACTERIAL                                 FURUNCULOSIS,CARBUNCLE,ECTHYMA, 
                                                            
FOLLICULITIS,IMPETIGO,ERYTHRASMA 
 
FUNGAL                       -                 DERMATOPHYTOSIS,CANDIDIASIS, 
                                                            PITYRIASIS VERSICOLOR 
 
  VIRAL                           -                 HERPES ZOSTER,HERPES SIMPLEX 
  
 
DIABETIC TREATMENT RELATED COMPLICATIONS : 
INSULIN-                
PIGMENTATION,INFLAMMATION,ULCER,SCAR,KELOID,LIPOHYPERTR
OPHY,LIPOATROPHY,DRUG REACTIONS 
O.H.A                               -                 PHOTOSENSITIVITY,LICHENOID 
                                                            
ERUPTIONS,ECZEMATOUSREACTION,SJS 
 
OTHER SKIN LESIONS     :           XANTHOMAS,XANTHELASMA 
                                                            PERFORATING DERMATOSIS 
                                                            GRANULOMA ANNULARE 
                                                            NECROBIOSIS LIPOIDICA 
 
ASSOCIATED DISEASES   :VITILIGO  
                                                            ALOPECIA AREATA 
                                                            PSORIASIS 
                                                            LICHEN PLANUS 
                                                            HYPOTHROIDISM 
                                                            BULLOUS PEMPHIGOID 
                                                            CUTANEOUS AMYLOIDOSIS 
CLINICAL PHOTOGRAPH NO: 
INVESTIGATIONS:  
HAEMATOLOGY : 
Hb% 
                TC 
                DC 
                ESR 
                BLOOD SUGAR   
  
                BLOOD UREA 
                SERUM CREATININE 
URINE ANALYSIS  : 
                ALBUMIN 
                 SUGAR 
SKIN BIOPSY: 
 
WET MOUNT  IN KOH 10%-40% : 
GRAM STAIN EXAMINATION OF SMEAR : 
SPECIFIC INVESTIGATIONS    : 
LIPID PROFILE  
 
                 GLYCOSYLATED HEMOGLOBIN 
VASCULAR SURGEON OPINION(DIABETIC ULCER) 
 
ORTHOPAEDIC SURGEON OPINION(DIABETIC FOOT) 
  
  
   
  
   
  
 
  
   
 
  
   
  
 
 
  
MASTER CHART 
 
  
 
   
   
  
Key for Master Chart 
TIDM -  Type 1 Diabetes mellitus 
TIDM - Type 2 Diabetes Mellitus 
1. Sex 
M - Male 
F - Female  
2. INFECTIONS 
OT - ORAL THRUSH 
P - PARONYCHIA 
I - INTERTRIGO 
BP - BALANO POSTHITIS 
AC - ANGULAR CHELITIS 
VVC - VULVO VAGINAL CANDIDIASIS 
TC - TINEA CORPORIS 
TP -  TINEA PEDIS 
T.cru - TINEA CRURIS 
TV - TINEA VERSICOLOR 
OI - OTHER INFECTIONS 
KP - KERATOLYSIS PUNCTATA 
VZ - VARICELLA ZOSTER 
  
C - CELLULITIS 
E - ERYSIPELAS 
V - VERUCCA 
M - MUCOR MYCOSIS 
 
3. NEUROPATHY 
S - SENSORY 
A - AUTONOMIC 
4. HYPERLIPIDEMIA RELATED 
AN - ACANTHOSIS NIGRICANS 
X - XANTHELASMA 
5. GRANULOMATDUS DISORDERS 
GA - GRANULOMA ANNULARE 
NLD - NECROBIOSIS LIPOIDICA 
6. STIFF SKIN, JOINTS 
CA - CHEIROARTHROPATHY 
S - SCLEREDEMA DIABETICORUM 
7. NAIL 
B - BEAU’S LINE 
O - ONYCHOMADESIS 
  
P - PTERYGIUM 
L - LEUKONYCHIA 
T - NAIL PLATE THICKENING 
8. TREATMENT RELATED 
K - KELOID 
L - LIPODYSTROPHY 
FDE - FIXED DRUG ERUPTION 
PS - PHOTOSENSITIVITY 
9. ASSOCIATED DERMATOSIS 
TP - TRUNKAL PRURITUS 
AP - ANOGENITAL PRURITUS 
DD - DIABETIC DERMOPATHY 
DB - DIABETIC BULLAE 
G - GANGRENE OF FOOT 
V - VITILIGO 
AA - ALOPECIA AREATA 
PM - PRETIBIAL MYXEDEMA 
MA/LA - MACULAR/LICHEN AMYLOIDOSIS 
  CAN - CHERRY ANGIOMA 
  Ps - PSORIASIS 
  BP - BULLOUS PEMPHIGOLD 
  Perf - PERFORATING FOLLICULITIS 
